Cindy Tahl - 06 May 2026 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Reporting relationship: Chief Legal and Compliance Officer
Issuer ticker: FATE
Reported as of: 06 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 May 2026, 16:00:36 UTC
Prior SEC filing: 16 Jan 2026
Next SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Cindy Tahl

Key filing fact

Cindy Tahl filed Form 4 for FATE THERAPEUTICS INC (FATE) on 07 May 2026.

Key facts

This page summarizes Cindy Tahl's Form 4 filing for FATE THERAPEUTICS INC (FATE).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 07 May 2026, 16:00.

Change

Previous filing in this sequence was filed on 16 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001655472 Primary reporting owner

TAHL CINDY

Relationship: Chief Legal and Compliance Officer
Address: C/O FATE THERAPEUTICS, INC., 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO
Signature: /s/ Cindy Tahl
Signature date: 07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FATE transaction

Common Stock

Options Exercise

Transaction value
Shares: +122,220
Change %: +25%
Price: $1.32^*
Shares after: 609,301
Date: 06 May 2026
Ownership: Direct

FATE transaction

Common Stock

Options Exercise

Transaction value
Shares: +44,444
Change %: +7.3%
Price: $1.05^*
Shares after: 653,745
Date: 06 May 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FATE transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -122,220
Change %: -44%
Price: $0.000000^*
Shares after: 152,780
Date: 06 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 122,220
Exercise price: $1.32
Footnotes: F1

FATE transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -44,444
Change %: -11%
Price: $0.000000^*
Shares after: 355,556
Date: 06 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 44,444
Exercise price: $1.05
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2025, such that all of the shares shall be fully vested and exercisable on January 1, 2028, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.

Footnote F2

The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.

SEC remarks

Chief Legal and Compliance Officer